1. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?. Issue 6815 (7th December 1991) Authors: Smyth, J F; Coleman, R E; Nicolson, M; Gallmeier, W M; Leonard, R C; Cornbleet, M A; Allan, S G; Upadhyaya, B K; Bruntsch, U Journal: BMJ Issue: Volume 303:Issue 6815(1991) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial. Issue 5 (30th April 2010) Authors: Navani, N; Nankivell, M; Stephens, R J; Parmar, M K B; Gilligan, D; Nicolson, M; Groen, H J M; van Meerbeeck, J P Journal: Thorax Issue: Volume 65:Issue 5(2010) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S85 British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC. (2nd December 2011) Authors: Ferry, D; Billingham, L J; Jarrett, H W; Dunlop, D; Thompson, J; Kumar, M; Skailes, G; Nicolson, M; Shah, R; Leonard, P; Chetiyawardana, A; Wells, P; Lewanski, C; Woll, P; Crosse, B; Hill, M; Pirrie, S; O'Byrne, K J Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients. (2nd December 2011) Authors: Billingham, L J; Gaunt, P; Jarrett, H W; Dunlop, D; Thompson, J; O'Byrne, K J; Kumar, M; Skailes, G; Nicolson, M; Shah, R; Leonard, P; Chetiyawardana, A; Wells, P; Lewanski, C; Woll, P; Crosse, B; Hill, M; Ferry, D Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S87 Delivered dose intensity of gemcitabine 1250 mg/m2 with cisplatin at 80 mg/m2 (GC80) and 50 mg/m2 (GC50) and carboplatin AUC 6 (GCb6) in a phase III trial of advanced non-small cell lung cancer (NSCLC): correlations with clinical outcomes. (2nd December 2011) Authors: Dunlop, D; Ferry, D; Jarrett, H W; Billingham, L J; Thompson, J; Kumar, M; Skailes, G; Nicolson, M; Shah, R; Leonard, P; Chetiyawardana, A; Wells, P; Lewanski, C; Woll, P; Crosse, B; O'Byrne, K J Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TGF-β2 mediated secretion of sCTLA-4 from regulatory T cells. Issue 1 (December 2015) Authors: Khanolkar, R; Rajpara, S; Muller, F; Depasquale, I; Lawson, L; Barker, RN; Nicolson, M; Ormerod, AD; Ward, FJ Journal: Journal of inflammation Issue: Volume 12:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗